Journal Information

Statistics

Follow this link to access the full text of the article

TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D (GPRC5D) CD3 BISPECIFIC ANTIBODY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 STUDY RESULTS
JG Berdejaa, AY Krishnanb, A Oriolc, NWV Donkd, P Rodríguez-Oteroe, E Askarif, M Mateosg, MC Minnemah, LJ Costai, R Veronaj, BW Hilderqj, S Girgisqj, T Priorj, JS Russellj, JD Goldbergk, A Charil
a Sarah Cannon Research Institute and Tennessee Oncology, Nashville, United States
b City of Hope Comprehensive Cancer Center, Duarte, United States
c Institut Català d'Oncologia and Institut Josep Carreras. Hospital Germans Trias i Pujol, Barcelona, Spain
d Amsterdam University Medical Center, VU University Medical Center, Amsterdam, Netherlands
e Clínica Universidad de Navarra, Navarra, Spain
f Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
g Hospital Clínico Universitario de Salamanca, Salamanca, Spain
h University Medical Center Utrecht, Utrecht, Netherlands
i University of Alabama at Birmingham, Birmingham, United States
j Janssen R&D, Spring House, United States
k Janssen R&D, Raritan, United States
l Mount Sinai School of Medicine, New York, United States
Ver más
Read
2333
Times
was read the article
965
Total PDF
1368
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 7 2 3 5
2025 6 45 19 64
2025 5 43 15 58
2025 4 33 10 43
2025 3 55 16 71
2025 2 37 17 54
2025 1 37 16 53
2024 12 29 8 37
2024 11 43 28 71
2024 10 29 30 59
2024 9 57 27 84
2024 8 41 39 80
2024 7 41 28 69
2024 6 38 33 71
2024 5 42 49 91
2024 4 39 21 60
2024 3 38 24 62
2024 2 32 25 57
2024 1 30 19 49
2023 12 25 18 43
2023 11 55 47 102
2023 10 30 25 55
2023 9 42 24 66
2023 8 26 16 42
2023 7 32 14 46
2023 6 38 13 51
2023 5 30 15 45
2023 4 27 15 42
2023 3 17 15 32
2023 2 17 26 43
2023 1 14 3 17
2022 12 24 15 39
2022 11 28 24 52
2022 10 31 29 60
2022 9 29 28 57
2022 8 19 21 40
2022 7 22 28 50
2022 6 23 17 40
2022 5 17 20 37
2022 4 21 20 41
2022 3 24 22 46
2022 2 18 19 37
2022 1 14 22 36
2021 12 15 16 31
2021 11 14 17 31
2021 10 5 9 14
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy